131 related articles for article (PubMed ID: 32372739)
21. Clozapine Rechallenge After Neutropenia or Leucopenia.
Prokopez CR; Armesto AR; Gil Aguer MF; Balda MV; Papale RM; Bignone IM; Daray FM
J Clin Psychopharmacol; 2016 Aug; 36(4):377-80. PubMed ID: 27232877
[TBL] [Abstract][Full Text] [Related]
22. Siltuximab and hematologic malignancies. A focus in non Hodgkin lymphoma.
Ferrario A; Merli M; Basilico C; Maffioli M; Passamonti F
Expert Opin Investig Drugs; 2017 Mar; 26(3):367-373. PubMed ID: 28140696
[TBL] [Abstract][Full Text] [Related]
23. Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study.
Sant M; Minicozzi P; Mounier M; Anderson LA; Brenner H; Holleczek B; Marcos-Gragera R; Maynadié M; Monnereau A; Osca-Gelis G; Visser O; De Angelis R;
Lancet Oncol; 2014 Aug; 15(9):931-42. PubMed ID: 25030467
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for cytarabine-induced cutaneous toxicity in patients with haematological malignancies.
Morio K; Mizuki M; Sozu T; Uejima E
Chemotherapy; 2014; 60(3):168-73. PubMed ID: 25823612
[TBL] [Abstract][Full Text] [Related]
25. According to the WHO clozapine pharmacovigilance database, the United Kingdom accounts for 968 fatal outcomes versus 892 in the rest of the world.
de Leon J
Br J Clin Pharmacol; 2022 Dec; 88(12):5434-5435. PubMed ID: 36106607
[No Abstract] [Full Text] [Related]
26. Reporting Patterns of Sialorrhea Comparing Users of Clozapine to Users of Other Antipsychotics: A Disproportionality Analysis Using VigiBase.
Man WH; Wilting I; Souverein P; Meyboom R; Egberts T; Heerdink ER
J Clin Psychopharmacol; 2020; 40(3):283-286. PubMed ID: 32332463
[TBL] [Abstract][Full Text] [Related]
27. Haematological monitoring with clozapine therapy in India.
Tharyan P
Br J Psychiatry; 1998 Jun; 172():540. PubMed ID: 9828998
[No Abstract] [Full Text] [Related]
28. A systematic review and meta-analysis of haematological malignancies in residents living near petrochemical facilities.
Jephcote C; Brown D; Verbeek T; Mah A
Environ Health; 2020 May; 19(1):53. PubMed ID: 32430062
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the safety and efficacy of low-dose rasburicase in critically ill children with haematological malignancies.
Pei Y; Li Y; Liang Y; Xu L; Huang X; Li Y; Tang W; Jiang X
Int J Clin Pharm; 2020 Dec; 42(6):1440-1446. PubMed ID: 32974856
[TBL] [Abstract][Full Text] [Related]
30. Clozapine-Induced Gastrointestinal Hypomotility: A 22-Year Bi-National Pharmacovigilance Study of Serious or Fatal 'Slow Gut' Reactions, and Comparison with International Drug Safety Advice.
Every-Palmer S; Ellis PM
CNS Drugs; 2017 Aug; 31(8):699-709. PubMed ID: 28623627
[TBL] [Abstract][Full Text] [Related]
31. Urinary trypsin inhibitor levels in the urine of patients with haematological malignancies.
Takubo T; Kumura T; Nakamae H; Aoyama Y; Koh KR; Ohta K; Yamane T; Hino M; Kanashima H; Kamitani T; Ohta T; Kuwajima S; Tatsumi N
Haematologia (Budap); 2001; 31(3):267-72. PubMed ID: 11855791
[TBL] [Abstract][Full Text] [Related]
32. What is known and unknown about chemotherapy-related cognitive impairment in patients with haematological malignancies and areas of needed research.
Williams AM; Zent CS; Janelsins MC
Br J Haematol; 2016 Sep; 174(6):835-46. PubMed ID: 27391367
[TBL] [Abstract][Full Text] [Related]
33. Reporting of clozapine-induced gastrointestinal hypomotility and factors associated with fatal outcomes in Canada: A pharmacovigilance database study.
Liu CL; Maruf AA; Bousman CA
Psychiatry Res; 2020 Aug; 290():113048. PubMed ID: 32474068
[TBL] [Abstract][Full Text] [Related]
34. A pilot study on parvovirus B19 infection in paediatric haematological malignancies.
Kishore J; Sen M; Kumar A; Kumar A
Indian J Med Res; 2011 Apr; 133(4):407-13. PubMed ID: 21537094
[TBL] [Abstract][Full Text] [Related]
35. Susceptibility of patients receiving chemotherapy for haematological malignancies to scabies.
Hosoi H; Nishikawa S; Kida Y; Kishi T; Murata S; Iwamoto M; Toyoda Y; Yamada Y; Ikeda T; Sonoki T
J Hosp Infect; 2020 Nov; 106(3):594-599. PubMed ID: 32866631
[TBL] [Abstract][Full Text] [Related]
36. The Patient Remote Intervention and Symptom Management System (PRISMS) - a Telehealth- mediated intervention enabling real-time monitoring of chemotherapy side-effects in patients with haematological malignancies: study protocol for a randomised controlled trial.
Breen S; Ritchie D; Schofield P; Hsueh YS; Gough K; Santamaria N; Kamateros R; Maguire R; Kearney N; Aranda S
Trials; 2015 Oct; 16():472. PubMed ID: 26481873
[TBL] [Abstract][Full Text] [Related]
37. Clozapine haematological monitoring for neutropenia: a global perspective.
Oloyede E; Blackman G; Whiskey E; Bachmann C; Dzahini O; Shergill S; Taylor D; McGuire P; MacCabe J
Epidemiol Psychiatr Sci; 2022 Nov; 31():e83. PubMed ID: 36426600
[TBL] [Abstract][Full Text] [Related]
38. Need to bleed? Clozapine haematological monitoring approaches a time for change.
Whiskey E; Dzahini O; Ramsay R; O'Flynn D; Mijovic A; Gaughran F; MacCabe J; Shergill S; Taylor D
Int Clin Psychopharmacol; 2019 Sep; 34(5):264-268. PubMed ID: 30882426
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological activation of the p53 pathway in haematological malignancies.
Saha MN; Micallef J; Qiu L; Chang H
J Clin Pathol; 2010 Mar; 63(3):204-9. PubMed ID: 19955555
[TBL] [Abstract][Full Text] [Related]
40. [Optimising therapy in patients with haematological malignancies].
Dumontet C
Bull Cancer; 2008 Oct; 95(10):959-62. PubMed ID: 19004726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
